BU-NOT-SET

CONTACT US
Dispensing traceability over the counter
  • Manufacturing
Eyes
Insight
The Final Countdown: CDMO focus areas before February 2019
  • Manufacturing
Eyes
Insight
Changing dynamics: the CDMO market in focus
  • Industry trends
Eyes
Insight
Formulation development trends
  • Drug product
Eyes
Insight
One-year countdown to Brexit
  • Industry trends
Eyes
Insight
High throughput screening platform for liquid formulation design
  • Drug product
Man lab
White paper
Could limited access to the EU Hub threaten serialization readiness?
  • Manufacturing
Eyes
Insight
On the pathway to clinic, solubility remains one of the biggest hurdles: CDMO
  • Drug product
Eyes
Insight
US DSCSA: data standardisation
  • Manufacturing
Eyes
Insight
Insight
  • Manufacturing
Is outsourcing the most viable pathway for innovators?
Case study
  • Drug product
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
Insight
  • Industry trends
Recipharm Wins two 2020 CMO Leadership Awards
Insight
  • Corporate
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
Insight
  • Manufacturing
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
Brochure
  • Corporate
Recipharm 25 years
Fact sheet
  • Drug substance
API product list
Insight
  • Drug substance
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
Insight
  • Industry trends
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19